Showing results (481-490 of 597) with videos related to
Sort By:
Pageof 60
Parkinsonism & Related Disorders|January 24, 2019
A significant inflation in TGM6 genetic risk casts doubt in its causation in spinocerebellar ataxia type 35Jasmine L F Fung, Mandy H Y Tsang, Gordon K C Leung, et al.International Journal of Cancer|February 20, 2015
Modulatory effects of adiponectin on the polarization of tumor-associated macrophagesJiao Peng, Julia Y Tsang, Derek H Ho, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
A phase I trial of a recombinant vaccinia virus expressing prostate-specific antigen in advanced prostate cancerJ P Eder, P W Kantoff, K Roper, et al.Open Forum Infectious Diseases|April 1, 2024
COVID-19 Immunologic Antiviral Therapy With Omalizumab (CIAO)-a Randomized Controlled Clinical TrialMichelle Le, Lauren Khoury, Yang Lu, et al.Plos One|April 11, 2014
Management of spontaneously ruptured hepatocellular carcinomas in the radiofrequency ablation eraTan To Cheung, Ronnie T P Poon, Kenneth S H Chok, et al.Oncoimmunology|November 1, 2018
Epigenetic priming of both tumor and NK cells augments antibody-dependent cellular cytotoxicity elicited by the anti-PD-L1 antibody avelumab against multiple carcinoma cell typesKristin C Hicks, Massimo Fantini, Renee N Donahue, et al.Pharmacopsychiatry|October 7, 2004
High dose antipsychotic use in schizophrenia: findings of the REAP (research on east Asia psychotropic prescriptions) studyK Sim, A Su, J Y Leong, et al.Infection Control and Hospital Epidemiology|March 6, 2020
Escalating infection control response to the rapidly evolving epidemiology of the coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong KongVincent C C Cheng, Shuk-Ching Wong, Jonathan H K Chen, et al.The Lancet. Oncology|February 14, 2012
Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trialRavi A Madan, Mahsa Mohebtash, Philip M Arlen, et al.Journal of Neurology|September 5, 2023
Investigating differences in young- and late-onset progressive supranuclear palsyBatoul A AlWazan, Indira Garcia-Cordero, Blas Couto, et al.Pageof 60